کاربرد الگوریتم های تکاملی چند هدفه خاکستری در بهینه سازی میزان دوز در روش براکی تراپی با میزان دوز بالا

نویسندگان
محمد محمدی نجف آبادی
داوود درویشی
دانشگاه پیام نور تهران
چکیده
مسائل برنامه ریزی درمان براکی تراپی با میزان دز بالا، شامل تعیین برنامه حرکتی یک منبع تابشی است به گونه ای که حجم های هدف به طور مناسب با دوز کافی پوشش داده شوند، در حالی که اندامها در معرض خطر اشعه فراتر از آستانه قابل قبول بالینی دریافت نکنند. هدف این مقاله، ارائه یک مدل بهینه سازی دو هدفه فازی است که به طور مستقیم، حالت چند بعدی بودن مسئله برنامه ریزی درمان براکی تراپی را در دو هدف لحاظ شده است. بنابراین فرایند تصمیم گیری برنامه ریزان درمان را هنگام ایجاد یک برنامه قابل قبول از نظر بالینی، ساده تر می کند. از طرفی با توجه به اینکه حجم دقیق تومور قابل تشخیص و محاسبه نیست، لذا از اعداد خاکستری در جهت محاسبه حجم تومور در مدل مسئله براکی تراپی استفاده شده است.

در این پژوهش از چهار الگوریتم تکاملی چند هدفه قدرتمند، الگوریتم های NSGA1-II، MOEA/D2، SPEA3-II و الگوریتم تکاملی چند هدفه خاکستری G-NSGA4-II استفاده شده است. این الگوریتم ها به جای ارائه ی تنها یک پاسخ بهینه، مجموعه ای از جواب های پارتو ایجاد می کنند که هیچ کدام بر دیگری برتری ندارند. نتایج بدست آمده از این چهار الگوریتم، نشان می دهند که الگوریتم تکاملی چند هدفه خاکستری G-NSGA-II ، هم به لحاظ کیفیت جوابها و هم به لحاظ حفظ تنوع در جوابها، و همچنین بخاطر ساختار خاکستری و عملگرهای خاکستری مورد استفاده در آن، بهترین الگوریتم تکاملی چند هدفه بین این چهار الگوریتم قدرتمند، برای بهینه سازی میزان دوز در مسئله براکی تراپی است که از وابستگی بین متغیرهای تصمیم گیری برای حل کارآمد آن بهره می برد. این نتایج بیانگر اثربخش بودن عملکرد این الگوریتم و همچنین مدل فازی دو هدفه در کوتاه کردن دوره درمان و افزایش دقت برنامه براکی تراپی می باشد.


عنوان مقاله English

Application of gray multi-objective evolutionary algorithms for dose optimization in high dose brachytherapy problems

نویسندگان English

Mohammad Mohammadi Najafabadi
Davood Darvishi
Payame Noor University
چکیده English

Background

Cancer is one of the great human challenges in all countries, both advanced and developing. Cancer treatment management can include surgery, chemotherapy, or radiation therapy [1]. Radiation therapy is done in two ways: Teletherapy and Brachytherapy. Brachytherapy involves the use of radiation sources to treat cancer by irradiating cancerous tissue from within the patient’s body [2]. But the dose and how to use this method has always been questionable for researchers. The purpose of this paper is to present a two-objective optimization model that directly summarizes the multidimensional nature of the problem of brachytherapy treatment planning in two objectives. Therefore, it simplifies the decision-making process of treatment planners when creating a clinically acceptable plan.



Methods

In the present study, the dose prescribed for an organ was evaluated by dosimetric indices listed in Table 1. For the present study, data from patients in the age range of 50 to 74 and mean age 62 years with a wide range of prostate volume between 23 and 103 cubic centimeters, and for the treatment of prostate cancer by brachytherapy from the Academic Medical Center (AMC, Amsterdam, the Netherlands) had participated. To compare brachytherapy programs with high interstitial dose, the dose rate was calculated with 192Ir beam with a radiation dose of 13 Gy, according to the standard protocol TG-43.

To begin with, computed tomography (CT) scans or magnetic resonance imaging (MRI) were taken from the patients pelvis, and entered into the treatment planning software for use in treatment planning sessions. BT treatment planners and specialists then determined the input catheters, target volumes, and OARs obtained from the medical images. Depending on the size and exact location of the target volumes, between 14 and 20 catheters entered the patient’s body, reaching the target volumes. After designing and approving an acceptable treatment plan, the catheters inserted into the patient’s body were connected to a retractor that controls the movement of the radiation source. After the treatment program, the source was returned to the retractor.



Results

According to this study, four multi-objective evolutionary algorithms, NSGA-II, MOEA / D, SPEA-II algorithms and G-NSGA-II (gray multi-objective evolutionary algorithm) have been used. Instead of providing only one optimal answer, these algorithms create a set of Pareto optimal answers, none of which is superior to the other. But they have better results compared to other methods. The results show that the G-NSGA-II (gray multi-objective evolutionary algorithm) is the best multi-objective evolutionary algorithm for both the quality of the answers and the diversity of the answers, as well as the gray structure and the gray operators used in it. Dose optimization is a problem in brachytherapy that uses the interdependence between decision variables to solve it efficiently. These results indicate the effectiveness of this algorithm in shortening the treatment period and increasing the accuracy of the brachytherapy program.



Conclusion

According to the obtained results, it can be stated that whether the main goal is the maximum coverage or the goal is the shortest possible time to reach the coverage above 95%, the best algorithm that can get a good answer for each patient is the G-NSGA-II (gray multi-objective evolutionary algorithm).



Ethical Considerations and Compliance with ethical guidelines

All ethical principles were considered in this article. In order to observe the ethical points in the truth, the researcher undertook to keep all the information in the questionnaire confidential. It also provides the results of the research to the respondents.



Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for profit sectors.



Conflicts of interest

The authors declared no conflict of interest

کلیدواژه‌ها English

Multi-objective optimization
Evolutionary algorithms
Brachytherapy
Gray systems theory
[1] Balderas, F., Fernandez, E., Gomez-Santillan, C., Cruz-Reyes, L., Rangel-Valdez, N., & Morales-Rodríguez, M. L. (2018). A grey mathematics approach for evolutionary multi-objective metaheuristic of project portfolio selection. In Fuzzy logic augmentation of neural and optimization algorithms: theoretical aspects and real applications (pp. 379-388). Springer, Cham.

[2] Bouter, A., Alderliesten, T., Witteveen, C., & Bosman, P. A. (2017, July). Exploiting linkage information in real-valued optimization with the real-valued gene-pool optimal mixing evolutionary algorithm. In Proceedings of the Genetic and Evolutionary Computation Conference (pp. 705-712).

[3] Bouter, A., Luong, N. H., Witteveen, C., Alderliesten, T., & Bosman, P. A. (2017, July). The multi-objective real-valued gene-pool optimal mixing evolutionary algorithm. In Proceedings of the Genetic and Evolutionary Computation Conference (pp. 537-544).

[4] Dushatskiy, A., Virgolin, M., Bouter, A., Thierens, D., & Bosman, P. A. (2021). Parameterless Gene-pool Optimal Mixing Evolutionary Algorithms. arXiv preprint arXiv:2109.05259.

[5] Ghaderi, N., Jung, J., Brüningk, S. C., Subramanian, A., Nassour, L., & Peacock, J. (2022). A Century of Fractionated Radiotherapy: How Mathematical Oncology Can Break the Rules. International Journal of Molecular Sciences, 23(3), 1316.

[6] Guthier, C. V., Orio III, P. F., Buzurovic, I., & Cormack, R. A. (2021). Knowledge‐based inverse treatment planning for low‐dose‐rate prostate brachytherapy. Medical Physics, 48(5), 2108-2117.

[7] Helou, J., D’Alimonte, L., Loblaw, A., Chung, H., Cheung, P., Szumacher, E., ... & Morton, G. (2015). High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success. Radiotherapy and Oncology, 115(1), 84-89.

[8] Lei, Y., Wang, T., Fu, Y., Roper, J., Jani, A. B., Liu, T., ... & Yang, X. (2021). Catheter position prediction using deep‐learning‐based multi‐atlas registration for high‐dose rate prostate brachytherapy. Medical Physics, 48(11), 7261-7270.

[9] Li, H., Lee, C. H., Chia, D., Lin, Z., Huang, W., & Tan, C. H. (2022). Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities. Diagnostics, 12(2), 289.

[10] Luong, N. H., Alderliesten, T., Bel, A., Niatsetski, Y., & Bosman, P. A. (2018). Application and benchmarking of multi-objective evolutionary algorithms on high-dose-rate brachytherapy planning for prostate cancer treatment. Swarm and Evolutionary Computation, 40, 37-52.

[11] Luong, N. H., Alderliesten, T., Bel, A., Niatsetski, Y., & Bosman, P. A. (2018). Application and benchmarking of multi-objective evolutionary algorithms on high-dose-rate brachytherapy planning for prostate cancer treatment. Swarm and Evolutionary Computation, 40, 37-52.

[12] Luong, N. H., Alderliesten, T., Pieters, B. R., Bel, A., Niatsetski, Y., & Bosman, P. A. (2019). Fast and insightful bi-objective optimization for prostate cancer treatment planning with high-dose-rate brachytherapy. Applied Soft Computing, 84, 105681.

[13] Luong, N. H., Bouter, A., Van Der Meer, M. C., Niatsetski, Y., Witteveen, C., Bel, A., ... & Bosman, P. A. (2017, July). Efficient, effective, and insightful tackling of the high-dose-rate brachytherapy treatment planning problem for prostate cancer using evolutionary multi-objective optimization algorithms. In Proceedings of the Genetic and Evolutionary Computation Conference Companion (pp. 1372-1379).

[14] Mohammadi, M., Nazif, H., Soltanian, F. (2022). Optimization of fuzzy model of high dose brachytherapy problem for the treatment of prostate cancer using evolutionary algorithms. Razi Journal of Medical sience, 12(28), 7043-2228.

[15] Morén, B., Larsson, T., & Tedgren, Å. C. (2021). Optimization in treatment planning of high dose‐rate brachytherapy—Review and analysis of mathematical models. Medical Physics, 48(5), 2057-2082.

[16] Murakami, Y., Soyano, T., Kozuka, T., Ushijima, M., Koizumi, Y., Miyauchi, H., ... & Oguchi, M. (2022). Dose-Based Radiomic Analysis (Dosiomics) for Intensity Modulated Radiation Therapy in Patients With Prostate Cancer: Correlation Between Planned Dose Distribution and Biochemical Failure. International Journal of Radiation Oncology* Biology* Physics, 112(1), 247-259.

[17] Prada, P. J., Ferri, M., Cardenal, J., Blanco, A. G., Anchuelo, J., de Cerio, I. D., ... & Ruiz, S. (2018). High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localized prostate cancer: Toxicity and 6-year biochemical results. Brachytherapy, 17(6), 845-851.

[18] Pu, G., Jiang, S., Yang, Z., Hu, Y., & Liu, Z. (2022). Deep reinforcement learning for treatment planning in high-dose-rate cervical brachytherapy. Physica Medica, 94, 1-7.

[19] Rahimi, I., Gandomi, A. H., Deb, K., Chen, F., & Nikoo, M. R. (2022). Scheduling by NSGA-II: Review and Bibliometric Analysis. Processes, 10(1), 98.

[20] Ruotsalainen, H., Miettinen, K., & Palmgren, J. E. (2010). Interactive multiobjective optimization for 3D HDR brachytherapy applying IND-NIMBUS. In New Developments in Multiple Objective and Goal Programming (pp. 117-131). Springer, Berlin, Heidelberg.

[21] Schipaanboord, B. W. K., Heijmen, B. J., & Breedveld, S. (2022). TBS-BAO: fully automated beam angle optimization for IMRT guided by a total-beam-space reference plan. Physics in Medicine & Biology.

[22] Tian, Y., Feng, Y., Wang, C., Cao, R., Zhang, X., Pei, X., ... & Jin, Y. (2022). A Large-Scale Combinatorial Many-Objective Evolutionary Algorithm for Intensity-Modulated Radiotherapy Planning. IEEE Transactions on Evolutionary Computation.

[23] Wang, C., Gonzalez, Y., Shen, C., Hrycushko, B., & Jia, X. (2021). Simultaneous needle catheter selection and dwell time optimization for preplanning of high-dose-rate brachytherapy of prostate cancer. Physics in Medicine & Biology, 66(5), 055028.

[24] Zitzler, E., Laumanns, M., & Thiele, L. (2001). SPEA2: Improving the strength Pareto evolutionary algorithm. TIK-report, 103.